Target intelligence / Profile preview

Nuclear transcription factor Y subunit beta (NFYB)

Target
NFYB
Molecular classification
Transcription factor, DNA-binding protein
01

Overview

Nuclear transcription factor Y subunit beta is a component of the trimeric transcription factor NF-Y, which binds specifically to CCAAT box motifs in the promoters of a wide variety of genes. NFYB, along with subunits NF-YA and NF-YC, forms a highly conserved heterotrimer necessary for specific DNA binding and activation of target gene transcription. The subunit itself contains a histone-like motif and dimerizes with NF-YC before associating with NF-YA. NFYB has a central role in the regulation of gene expression related to cell cycle progression, endoplasmic reticulum stress, and DNA damage response, and it has been implicated in cancer development and chemotherapy resistance, particularly through pathways such as E2F1. The protein itself does not function as a therapeutic target of small molecule drugs or biologics as of current knowledge, but its activity and expression can influence cellular phenotypes relevant to drug resistance and disease progression.

Other names
CBF-AHAP3NF-YBCCAAT-binding factor subunit BHeme activator protein 3
02

Biological functions

Transcriptional regulationCell cycle regulationDNA-bindingControl of gene expressionRegulation of endoplasmic reticulum stress responsesResponse to DNA damage
03

Disease associations

Cancer (regulation of cell cycle genes; role in chemoresistance)Other (roles related to stress responses and cell proliferation; specific disease associations are still emerging)

Beyond the preview

Go deeper on Nuclear transcription factor Y subunit beta (NFYB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear transcription factor Y subunit beta (NFYB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call